フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Hutchmed (China) Ltd on Friday said it will receive a milestone payment from Takeda Pharmaceutical Co Ltd after Taked ...
Takeda Pharmaceutical Co Ltd on Thursday raised full year forecasts to reflect a stronger than anticipated first-half ...
Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan. The drug has bee ...
Ltd - Hong Kong-headquartered biopharmaceutical company - Notes that Takeda Pharmaceuticals Co Ltd received a notifica ...
Takeda Pharmaceutical Co Ltd on Thursday said annual revenue increased, though profit plummeted on increased expenses ...
Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc and Sumitomo Mitsui Financial Group Inc on Monday agreed to establi ...
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE PR...
Hutchmed (China) Ltd on Thursday announced that the Tokyo-based drug maker, Takeda Pharmaceutical Co Ltd, has receive ...
Takeda Pharmaceutical Co Ltd on Monday said profit fell in the first half of its financial year, despite revenue risi ...
Hutchmed (China) Ltd on Friday said Takeda Pharmaceutical Co Ltd has submitted a new drug application for cancer trea ...
Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent...
Takeda Pharmaceutical Co Ltd on Thursday kept its guidance for financial 2024 unchanged, after reporting a 15% drop i ...
Japanese pharmaceutical firm Takeda Pharmaceutical Co Ltd is voluntarily withdrawing its application for approval of ...
Japanese pharma firm Takeda Pharmaceuticals Co Ltd is voluntarily withdrawing its application for approval of a dengu ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約